Challenges and future perspectives for high-throughput chimeric antigen receptor T cell discovery
Current Opinion in Biotechnology · 2024
DOI: 10.1016/j.copbio.2024.103216 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Biotechnology, 2024. Verfasst von Savannah E Butler und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, High-Throughput Screening Assays, T-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, Dartmouth Cancer Center.
Abstract (Originalsprache)
Novel chimeric antigen receptor (CAR) T cell designs are being developed to overcome challenges with tumor recognition, trafficking, on-target but off-tumor binding, cytotoxicity, persistence, and immune suppression within the tumor microenvironment. Whereas traditional CAR engineering is an iterative, hypothesis-driven process in which novel designs are rationally constructed and tested for in vivo efficacy, drawing from the fields of small-molecule and protein-based therapeutic discovery, we consider how high-throughput, functional screening technologies are beginning to be applied for the development of promising CAR candidates. We review how the development of high-throughput screening methods has the potential to streamline the CAR discovery process, ultimately improving efficiency and clinical efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
- Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA; Thayer School of Engineering, Dartmouth College, Hanover, NH, USA. Electronic address: Margaret.E.Ackerman@Dartmouth.e…
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- Dartmouth Cancer Center
- National Institutes of Health
Zitieren
APA
Butler, S. E., & Ackerman, M. E. (2024). Challenges and future perspectives for high-throughput chimeric antigen receptor T cell discovery. Current Opinion in Biotechnology. https://doi.org/10.1016/j.copbio.2024.103216
Vancouver
Butler SE, Ackerman ME. Challenges and future perspectives for high-throughput chimeric antigen receptor T cell discovery. Current Opinion in Biotechnology. 2024. doi:10.1016/j.copbio.2024.103216
BibTeX
@article{Butler2024,
author = {Butler, Savannah E and Ackerman, Margaret E},
title = {Challenges and future perspectives for high-throughput chimeric antigen receptor T cell discovery},
journal = {Current Opinion in Biotechnology},
year = {2024},
doi = {10.1016/j.copbio.2024.103216}
}
EUVIMED